Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells

References

• Turski WA, Nakamura M, Todd WP, Carpenter BK, Whetsell WO Jr, Schwarcz R. Identification and quantification of kynurenic acid in human brain tissue. Brain Res 1988;454:164–9.
   PubMedGoogle Scholar
• Perkins MN, Stone TW. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 1982;247:184–7.
   PubMed Web of Science ®Google Scholar
• Birch PJ, Grossman CJ, Hayes AG. Kynurenic acid antagonizes responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 1988;154:85–7.
   PubMed Web of Science ®Google Scholar
• Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX. The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications. J Neurosci 2001;21:7463–73.
   PubMed Web of Science ®Google Scholar
• Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 2006;281:22021–8.
   PubMed Web of Science ®Google Scholar
• Okuno E, Nakamura M, Schwarcz R. Two kynurenine aminotransferases in human brain. Brain Res 1991;542:307–12.
   PubMed Web of Science ®Google Scholar
• Yu P, Li Z, Zhang L, Tagle DA, Cai T. Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene 2006;365:111–18.
   PubMed Web of Science ®Google Scholar
• Han Q, Cai T, Tagle DA, Li J. Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases. BMC Biochem 2010;11:19–29.
   PubMedGoogle Scholar
• Guidetti P, Okuno E, Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 1997;50:457–65.
   PubMed Web of Science ®Google Scholar
• Han Q, Cai T, Tagle DA, Li J. Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci 2010;67:353–68.
   PubMed Web of Science ®Google Scholar
• Kuc D, Rahnama M, Tomaszewski T, Rzeski W, Wejksza K, Urbanik-Sypniewska T, Kynurenic acid in human saliva-does it influence oral microflora? Pharmacol Rep 2006;58:393–8.
   PubMedGoogle Scholar
• Kuc D, Zgrajka W, Parada-Turska J, Urbanik-Sypniewska T, Turski WA. Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids 2008;35:503–5.
   PubMedGoogle Scholar
• Paluszkiewicz P, Zgrajka W, Saran T, Schabowski J, Piedra JL, Fedkiv O, High concentration of kynurenic acid in bile and pancreatic juice. Amino Acids 2009;37:637–41.
   PubMedGoogle Scholar
• Turski MP, Turska M, Zgrajka W, Kuc D, Turski WA. Presence of kynurenic acid in food and honeybee products. Amino Acids 2009;36:75–80.
   PubMed Web of Science ®Google Scholar
• Han Q, Fang J, Li J. Kynurenine aminotransferase and glutamine transaminase K of Escherichia coli: identity with aspartate aminotransferase. Biochem J 2001;360:617–23.
   PubMedGoogle Scholar
• Turski WA, Gramsbergen JB, Traitler H, Schwarcz R. Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J Neurochem 1989;52:1629–36.
   PubMedGoogle Scholar
• Litchfield JT, Wilcoxon FA. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96:99–113.
   PubMed Web of Science ®Google Scholar
• Glavin GB, Pinsky C. Kynurenic acid attenuates experimental ulcer formation and basal gastric acid secretion in rats. Res Commun Chem Pathol Pharmacol 1989;64:111–19.
   PubMedGoogle Scholar
• Glavin GB, Bose R, Pinsky C. Kynurenic acid protects against gastroduodenal ulceration in mice injected with extracts from poisonous Atlantic shellfish. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:569–72.
   PubMedGoogle Scholar
• Glavin GB, Pinsky C, Bose R. Gastrointestinal effects of contaminated mussels and putative antidotes thereof. Canad Dis Wkly Rep 1990;16:111–15.
   PubMedGoogle Scholar
• Kaszaki J, Palasthy Z, Erczes D, Racz A, Torday C, Varga G, Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs. Neurogastroenterol Motil 2008;20:3–62.
   Google Scholar
• Wejksza K, Rzeski W, Parada-Turska J, Zdzisinska B, Rejdak R, Kocki T, Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor. Naunyn Schmiedebergs Arch Pharmacol 2004;369:300–4.
   PubMedGoogle Scholar
• Wejksza K, Rzeski W, Okuno E, Kandefer-Szerszen M, Albrecht J, Turski WA. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93). Neurochem Res 2005;30:963–8.
   PubMedGoogle Scholar
• Rzeski W, Kocki T, Dybel A, Wejksza K, Zdzisińska B, Kandefer-Szerszeń M, Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons. J Neurosci Res 2005;80:677–82.
   PubMedGoogle Scholar
• Wejksza K, Rzeski W, Turski WA, Hilgier W, Dybel A, Albrecht J. Ammonia at pathophysiologically relevant concentrations activates kynurenic acid synthesis in cultured astrocytes and neurons. Neurotoxicology 2006;27:619–22.
   PubMedGoogle Scholar
• Kiss C, Ceresoli-Borroni G, Guidetti P, Zielke CL, Zielke HR, Schwarcz R. Kynurenate production by cultured human astrocytes. J Neural Transm 2003;110:1–14.
   PubMed Web of Science ®Google Scholar
• Stazka J, Luchowski P, Wielosz M, Kleinrok Z, Urbanska EM. Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine. Eur J Pharmacol 2002;448:133–7.
   PubMedGoogle Scholar
• Gramsbergen JB, Hodgkins PS, Rassoulpour A, Turski WA, Guidetti P, Schwarcz R. Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem 1997;69:290–8.
   PubMedGoogle Scholar
• Liu MT, Rothstein JD, Gershon MD, Kirchgessner AL. Glutamatergic enteric neurons. J Neurosci 1997;17:4764–84.
   PubMed Web of Science ®Google Scholar
• Kirchgessner AL, Liu MT. Immunohistochemical localization of nicotinic acetylcholine receptors in the guinea pig bowel and pancreas. J Comp Neurol 1998;390:497–51.
   PubMedGoogle Scholar
• Moroni F, Fossati S, Chiarugi A, Cozzi A. Kynurenic acid actions in brain and periphery. Int Congr Ser 2007;1304:305–13.
   Google Scholar
• DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci 2010;115:89–97.
   PubMed Web of Science ®Google Scholar
• Fujii-Kuriyama Y, Kawajiri K. Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc Jpn Acad Ser B Phys Biol Sci 2010;86:40–53.
   PubMed Web of Science ®Google Scholar
• Kawajiri K, Kobayashi Y, Ohtake F, Ikuta T, Matsushita Y, Mimura J, Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in APCmin/ţ mice with natural ligands. Proc Natl Acad Sci USA 2009;106:13481–6.
   PubMed Web of Science ®Google Scholar
• Vezzani A, Gramsbergen JB, Versari P, Stasi MA, Procaccio F, Schwarcz R. Kynurenic acid synthesis by human glioma. J Neurol Sci 1990;99:51–7.
   PubMedGoogle Scholar
• Zdzisińska B, Wejksza K, Walter-Croneck A, Turski WA, Kandefer-Szerszeń M. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients. Leuk Res 2010;34:38–45.
   PubMed Web of Science ®Google Scholar
• Kocki T, Dolinska M, Dybel A, Urbanska EM, Turski WA, Albrecht J. Regulation of kynurenic acid synthesis in C6 glioma cells. J Neurosci Res 2002;68:622–6.
   PubMedGoogle Scholar
• Tankiewicz A, Dziemiańczyk D, Buczko P, Szarmach IJ, Grabowska SZ, Pawlak D. Tryptophan and its metabolites in patients with oral squamous cell carcinoma: preliminary study. Adv Med Sci 2006;51:221–4.
   PubMedGoogle Scholar
• Di Serio C, Cozzi A, Angeli I, Doria L, Micucci I, Pellerito S, Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro. Cell Mol Neurobiol 2005;25:981–93.
   PubMedGoogle Scholar
• Stepulak A, Luksch H, Gebhardt C, Uckermann O, Marzahn J, Sifringer M, Expression of glutamate receptor subunits in human cancers. Histochem Cell Biol 2009;132:435–45.
   PubMed Web of Science ®Google Scholar
• Parada-Turska J, Rzeski W, Zgrajka W, Majdan M, Kandefer-Szerszeń M, Turski W. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatol Int 2006;26:422–6.
   PubMed Web of Science ®Google Scholar
• Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107–11.
   PubMed Web of Science ®Google Scholar
• Palena C, Schlom J. Vaccines against human carcinomas: strategies to improve antitumor immune responses. J Biomed Biotechnol 2010;2010:380697–709.
   PubMedGoogle Scholar